Graeme Laver

1.3k total citations
18 papers, 996 citations indexed

About

Graeme Laver is a scholar working on Epidemiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Graeme Laver has authored 18 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Graeme Laver's work include Influenza Virus Research Studies (11 papers), Bacteriophages and microbial interactions (4 papers) and Glycosylation and Glycoproteins Research (4 papers). Graeme Laver is often cited by papers focused on Influenza Virus Research Studies (11 papers), Bacteriophages and microbial interactions (4 papers) and Glycosylation and Glycoproteins Research (4 papers). Graeme Laver collaborates with scholars based in Australia, United States and United Kingdom. Graeme Laver's co-authors include Elspeth F. Garman, G.L. Taylor, Eric R. Vimr, S.J. Crennell, John A. Montgomery, Y.S. Babu, Shanta Bantia, Pooran Chand, Yahya El-Kattan and Tsu‐Hsing Lin and has published in prestigious journals such as Journal of Molecular Biology, Biochemistry and Philosophical Transactions of the Royal Society B Biological Sciences.

In The Last Decade

Graeme Laver

18 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme Laver Australia 13 592 563 262 124 104 18 996
W.G. Laver Australia 10 485 0.8× 383 0.7× 179 0.7× 101 0.8× 144 1.4× 14 767
Stuart W. Oliver Australia 7 816 1.4× 887 1.6× 489 1.9× 175 1.4× 180 1.7× 10 1.6k
Robert J. Fenton United Kingdom 15 497 0.8× 341 0.6× 269 1.0× 96 0.8× 48 0.5× 27 1.0k
Betty Jin Australia 9 1.0k 1.7× 1.1k 2.0× 661 2.5× 210 1.7× 224 2.2× 11 1.9k
James Merson United States 18 521 0.9× 638 1.1× 152 0.6× 196 1.6× 141 1.4× 27 1.4k
Andrea Medeiros Uruguay 19 358 0.6× 298 0.5× 406 1.5× 132 1.1× 48 0.5× 55 1.0k
Paul A. Escarpe United States 12 696 1.2× 476 0.8× 248 0.9× 115 0.9× 106 1.0× 15 1.0k
Evelien Vanderlinden Belgium 19 529 0.9× 400 0.7× 285 1.1× 165 1.3× 44 0.4× 35 996
Yih‐Shyun E. Cheng Taiwan 25 688 1.2× 896 1.6× 574 2.2× 385 3.1× 168 1.6× 37 1.8k
Yahya El-Kattan United States 10 496 0.8× 458 0.8× 363 1.4× 72 0.6× 68 0.7× 19 957

Countries citing papers authored by Graeme Laver

Since Specialization
Citations

This map shows the geographic impact of Graeme Laver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Laver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Laver more than expected).

Fields of papers citing papers by Graeme Laver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Laver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Laver. The network helps show where Graeme Laver may publish in the future.

Co-authorship network of co-authors of Graeme Laver

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Laver. A scholar is included among the top collaborators of Graeme Laver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Laver. Graeme Laver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kishida, Noriko, Yoshihiro Sakoda, Gui‐Rong Bai, et al.. (2008). H2N5 influenza virus isolates from terns in Australia: genetic reassortants between those of the Eurasian and American lineages. Virus Genes. 37(1). 16–21. 35 indexed citations
2.
Laver, Graeme. (2006). Antiviral Drugs for Influenza: Tamiflu ® Past, Present and Future. Future Virology. 1(5). 577–586. 11 indexed citations
3.
Wang, Gary T., Sheldon Wang, Robert G. Gentles, et al.. (2004). Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Bioorganic & Medicinal Chemistry Letters. 15(1). 125–128. 16 indexed citations
4.
Garman, Elspeth F. & Graeme Laver. (2004). Controlling Influenza by Inhibiting the Viruss Neuraminidase. Current Drug Targets. 5(2). 119–136. 48 indexed citations
5.
Stoll, Vincent S., Kent D. Stewart, Clarence J. Maring, et al.. (2003). Influenza Neuraminidase Inhibitors:  Structure-Based Design of a Novel Inhibitor Series. Biochemistry. 42(3). 718–727. 98 indexed citations
6.
Laver, Graeme & Elspeth F. Garman. (2002). Pandemic influenza: its origin and control. Microbes and Infection. 4(13). 1309–1316. 28 indexed citations
7.
Laver, Graeme, et al.. (2001). Introduction. Philosophical Transactions of the Royal Society B Biological Sciences. 356(1416). 1813–1815. 1 indexed citations
8.
Babu, Y.S., Pooran Chand, Shanta Bantia, et al.. (2000). BCX-1812 (RWJ-270201):  Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design. Journal of Medicinal Chemistry. 43(19). 3482–3486. 307 indexed citations
9.
Atigadda, Venkatram R., Wayne J. Brouillette, Y.S. Babu, et al.. (1999). Hydrophobic benzoic acids as inhibitors of influenza neuraminidase. Bioorganic & Medicinal Chemistry. 7(11). 2487–2497. 26 indexed citations
10.
Atigadda, Venkatram R., Wayne J. Brouillette, Shoukath M. Ali, et al.. (1999). Potent Inhibition of Influenza Sialidase by a Benzoic Acid Containing a 2-Pyrrolidinone Substituent. Journal of Medicinal Chemistry. 42(13). 2332–2343. 45 indexed citations
11.
Crennell, S.J., Elspeth F. Garman, A. VASELLA, et al.. (1996). The Structures ofSalmonella typhimuriumLT2 Neuraminidase and its Complexes with Three Inhibitors at High Resolution. Journal of Molecular Biology. 259(2). 264–280. 73 indexed citations
12.
Janakiraman, Musiri N., et al.. (1995). A Sialic Acid-derived Phosphonate Analog Inhibits Different Strains of Influenza Virus Neuraminidase with Different Efficiencies. Journal of Molecular Biology. 245(5). 623–634. 62 indexed citations
13.
Crennell, S.J., Elspeth F. Garman, Graeme Laver, Eric R. Vimr, & G.L. Taylor. (1994). Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure. 2(6). 535–544. 176 indexed citations
14.
Taylor, G.L., Elspeth F. Garman, Robert G. Webster, Takehiko Saito, & Graeme Laver. (1993). Crystallization and Preliminary X-ray Studies of Influenza A Virus Neuraminidase of Subtypes N5, N6, N8 and N9. Journal of Molecular Biology. 230(1). 345–348. 12 indexed citations
15.
Taylor, G.L., et al.. (1992). Crystallization and preliminary crystallographic study of neuraminidase from Micromonospora viridifaciens. Journal of Molecular Biology. 225(4). 1135–1136. 6 indexed citations
16.
Taylor, G.L., Eric R. Vimr, Elspeth F. Garman, & Graeme Laver. (1992). Purification, crystallization and preliminary crystallographic study of neuraminidase from Vibrio cholerae and Salmonella typhimurium LT2. Journal of Molecular Biology. 226(4). 1287–1290. 21 indexed citations
17.
Nestorowicz, Ann, Graeme Laver, & David C. Jackson. (1985). Antigenic Determinants of Influenza Virus Haemagglutinin. X. A Comparison of the Physical and Antigenic Properties of Monomeric and Trimeric Forms. Journal of General Virology. 66(8). 1687–1695. 30 indexed citations
18.
Laver, Graeme. (1978). The Hemagglutinin of Influenza Viruses: Structure, Immunology, and Biological Function. Summary of a Meeting. The Journal of Infectious Diseases. 138(1). 105–109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.G. Laver Breakdown of academic impact, for papers by Stuart W. Oliver Breakdown of academic impact, for papers by Robert J. Fenton Breakdown of academic impact, for papers by Betty Jin Breakdown of academic impact, for papers by James Merson Breakdown of academic impact, for papers by Andrea Medeiros Breakdown of academic impact, for papers by Paul A. Escarpe Breakdown of academic impact, for papers by Evelien Vanderlinden Breakdown of academic impact, for papers by Yih‐Shyun E. Cheng Breakdown of academic impact, for papers by Yahya El-Kattan
Rankless by CCL
2026